Last reviewed · How we verify
Biodesign Otologic graft
At a glance
| Generic name | Biodesign Otologic graft |
|---|---|
| Also known as | Porcine small intestine submucosa |
| Sponsor | Henry Ford Health System |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Biodesign® Otologic Repair Graft
- Use of Biodesign® Otologic Graft in Canal Wall Down Mastoidectomy: A Prospective, Randomized Trial (PHASE4)
- Use of Biodesign® Otologic Graft in Tympanoplasty (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Biodesign Otologic graft CI brief — competitive landscape report
- Biodesign Otologic graft updates RSS · CI watch RSS
- Henry Ford Health System portfolio CI